US Broker Ratings

ADMA Biologics Inc (ADMA) Stock Analysis: A 154% Potential Upside Opportunity in Biotech

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company, is garnering significant attention from investors due to its promising outlook in the biotechnology sector. Headquartered in Ramsey, New Jersey, ADMA focuses..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 27.96% Potential Upside in the Biotech Space

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector with its robust pipeline of genetic medicines aimed at addressing diseases with high unmet medical needs. Based in..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A Compelling 32.56% Upside Potential for Investors

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 54.40% Potential Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of the precision oncology sector, offering innovative liquid biopsy tests and data solutions that are reshaping the landscape of cancer diagnostics..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Waters with an 8.42% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a notable player in the biotechnology sector, specializing in the development of RNA-targeted therapeutics and gene therapy solutions for rare diseases. With a..

Charles River Laboratories Inte (CRL) Stock Analysis: A Deep Dive into a 25% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a notable player within the Healthcare sector, more specifically in the Diagnostics & Research industry. With its headquarters in Wilmington, Massachusetts,..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR) presents an intriguing opportunity for investors in the burgeoning healthcare sector. As a prominent player in the medical devices industry, Integer Holdings boasts a market..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 22% Upside Potential in the Biotech Sector

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the healthcare sector, specifically within the biotechnology industry, is capturing the attention of investors with its promising upside potential. With a..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: 22.71% Potential Upside for This Healthcare Innovator

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, specializes in the development and commercialization of diagnostic and therapeutic products. With a market capitalization of $4.85 billion,..

DaVita Inc. (DVA) Stock Analysis: A Closer Look at Its Impressive 64.85% Return on Equity

DaVita Inc. (NYSE: DVA) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.32 billion, DaVita is a..

Glaukos Corporation (GKOS) Stock Analysis: 34% Potential Upside Shines in the Medical Device Sector

In the ever-evolving landscape of healthcare, Glaukos Corporation (GKOS) stands out as a pioneering force in the medical devices industry. With a market capitalization of $5.99 billion, this United States-based..

ICON plc (ICLR) Stock Analysis: Navigating a 31.95% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, ICON plc (ICLR) presents a compelling case for consideration. As a leading clinical research organization based in Dublin, Ireland, ICON specializes in..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring the 79% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a key player in the healthcare sector specializing in medical devices, is garnering significant attention from investors with its innovative cardiac monitoring solutions. Headquartered in..

Legend Biotech Corporation (LEGN): A Biotech Powerhouse with a Potential Upside of 240%

Legend Biotech Corporation (NASDAQ: LEGN) stands as a formidable player in the biotechnology sector, offering a compelling investment story centered on its groundbreaking work in cell therapies. With a market..

Fresenius Medical Care AG (FMS) Stock Analysis: Examining a 22.98% Potential Upside Amidst Challenges

Fresenius Medical Care AG (NYSE: FMS), a cornerstone in the healthcare sector specializing in dialysis services, stands as a pivotal player globally. With its operations spanning Germany, the United States,..

Chemed Corp (CHE) Stock Analysis: Exploring a 20% Potential Upside Amidst Market Challenges

For investors seeking stability in the healthcare sector, Chemed Corp (NYSE: CHE) presents an intriguing opportunity. With a current market capitalization of $5.2 billion, Chemed operates in the medical care..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Bold Bet on Biotech with 249% Upside Potential

Soleno Therapeutics, Inc. (SLNO) presents a compelling opportunity for investors seeking exposure to the biotechnology sector, particularly those interested in companies focusing on rare disease therapeutics. Headquartered in Redwood City,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Powerhouse with 125% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX) has emerged as a significant player in the biotechnology sector, captivating investor interest with its innovative approach to radiopharmaceuticals. The Australian-based company, boasting a market..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 41.93% Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, presents an intriguing case for investors seeking opportunities within the scientific instruments and analytical solutions..

AptarGroup, Inc. (ATR) Stock Analysis: A 33.62% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) is a noteworthy player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $7.85 billion, the company is a significant..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds